Monday, October 10, 2022 12:01:26 PM
No volume.
Recent LCTX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:15:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:10:17 PM
- Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update • Business Wire • 05/12/2026 08:01:00 PM
- Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026 • Business Wire • 05/05/2026 12:00:00 PM
- OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026 • Business Wire • 05/04/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2026 08:20:06 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2026 08:15:01 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2026 08:10:18 PM
- Lineage Announces Formation of Scientific Advisory Board • Business Wire • 04/13/2026 12:00:00 PM
- Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease • Business Wire • 03/24/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:05:10 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/11/2026 01:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 01:00:26 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/11/2026 01:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2026 12:51:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2026 12:50:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:10:24 PM
- Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • Business Wire • 03/05/2026 09:01:00 PM
- Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 • Business Wire • 02/26/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 12:30:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 12:30:03 AM
- Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience • Business Wire • 01/06/2026 01:00:00 PM
- Lineage Cell Therapeutics Issues Letter to Stockholders • Business Wire • 01/05/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2025 02:55:05 AM
